Yutaka Matsuo, Eiichi Nakamura et al.
(20.2 mg, 0.024 mmol, 86%) as black crystals. 1H NMR (400 MHz,
CDCl3/CS2): d=3.17 (s, 6H), 6.75 (s, 1H), 7.07–7.10 (m, 2H), 8.24–
8.27 ppm (m, 2H); 13C NMR (400 MHz, CDCl3/CS2): d=29.92, 40.51,
63.80, 67.27, 113.50, 128.15, 135.52, 136.41, 140.18, 140.22, 141.52, 141.62,
141.20, 142.03, 142.34, 142.49, 142.53, 143.23, 144.58, 144.62, 145.33,
145.35, 145.38, 145.48, 145.81, 146.09, 146.12, 146.15, 146.28, 146.36,
146.86, 147.23, 147.44, 149.84, 152.84, 154.62 ppm; HRMS (APCIÀ): m/z
calcd for C68H11N: 842.0891 [M]À; found: 842.0900.
1H NMR (500 MHz, CDCl3/CS2): d=0.60 (s, 3H), 0.64 (s, 3H), 2.55 (d,
J=14.6 Hz, 1H), 2.71 (d, J=14.6 Hz, 1H), 3.95 (s, 3H), 7.16–7.17 (m,
2H), 7.30–7.32 (m, 3H), 7.57–7.59 (m, 2H), 8.11–8.10 ppm (m, 2H);
13C NMR (500 MHz, CDCl3/CS2): d=21.91, 22.06, 29.77, 30.47, 55.35,
68.66, 110.17, 114.85, 119.86, 123.55, 125.62, 128.31, 128.71, 128.72, 131.38,
133.26, 134.17, 135.03, 135.69, 136.18, 136.31, 140.23, 140.29, 140.54,
140.58, 141.17, 141.23, 141.58, 141.65, 141.97, 142.02, 142.04, 142.11,
142.31, 142.56, 142.57, 142.93, 143.28, 143.59, 144.26, 144.31, 144.35,
144.54, 144.56, 144.65, 144.72, 144.73, 145.38, 145.41, 145.49, 145.51,
145.81, 145.93, 146.15, 146.18, 146.20, 146.28, 146.35, 146.36, 146.40,
146.67, 146.86, 147.27, 147.51, 147.82, 148.63, 154.14, 154.37, 157.47,
158.90, 159.49 ppm; HRMS (APCIÀ): m/z calcd for C76H20SiO: 977.1283
[M]À; found: 977.1330.
C60ACHTUNGTRENNUNG(C6H5)H (3)
The procedure described for compound
1
was performed by using
C6H5MgBr in place of 4-MeOC6H4MgBr to obtain compound 3 (205 mg,
1
0.257 mmol, 37%) as black crystals. H NMR (500 MHz, CDCl3/CS2): d=
6.73 (s, 1H), 7.08–7.11 (m, 2H), 7.22–7.25 (m, 1H), 7.28–7.31 ppm (m,
2H); 13C NMR (500 MHz, CDCl3/CS2): d=63.86, 66.54, 113.22, 128.31,
128.82, 128.94, 135.51, 136.62, 140.23, 140.29, 141.52, 141.61, 141.98,
142.03, 142.35, 142.48, 142.55, 143.31, 144.56, 144.62, 145.32, 145.35,
145.40, 145.47, 145.82, 146.09, 146.12, 146.15, 146.27, 146.36, 146.86,
147.07, 147.34, 149.85, 152.08 ppm; HRMS (APCIÀ): m/z calcd for
C66H6: 799.0470 [M]À; found: 799.04900.
À
C60(C6H4 NMe2)
G
The procedure described for compound 6a was performed by using com-
pound in place of compound to obtain compound (205 mg,
2
7
0.257 mmol, 37%) as black crystals. H NMR (500 MHz, CDCl3/CS2): d=
0.56 (s, 3H), 0.58 (s, 1H), 2.51 (d, J=14.6 Hz, 1H), 2.81 (d, J=14.7 Hz,
1H), 3.05 (s, 6H), 6.94–6.95 (m, 2H), 7.27–7.28 (m, 3H), 7.56–7.58 (m,
2H), 8.00–8.02 ppm (m, 2H); 13C NMR (500 MHz, CDCl3/CS2): d=21.95,
22.16, 29.76, 30.50, 55.35, 68.66, 110.14, 114.84, 117.26, 123.52, 125.66,
128.32, 131.71, 131.72, 134.17, 136.18, 135.69, 136.18, 136.31, 140.23,
140.29, 140.54, 140.58, 141.17, 141.23, 141.58, 141.65, 141.97, 142.02,
142.04, 142.11, 142.31, 142.56, 142.57, 142.93, 143.28, 143.59, 144.26,
144.31, 144.35, 144.54, 144.56, 144.65, 144.72, 144.73, 145.38, 145.41,
145.49, 145.51, 145.81, 145.93, 146.15, 146.19, 146.22, 146.27, 146.32,
146.36, 146.40, 146.67, 146.86, 146.93, 147.21, 147.59, 147.85, 148.65,
154.44, 154.36, 157.56, 158.79, 158.88 ppm; HRMS (APCIÀ): m/z calcd
for C77H23SiN: 990.1600 [M]À; found: 990.1624.
C60ACHTUNGTRENNUNG(C6H4CF3)H (4)
The procedure described for compound 1 was performed by using 4-
FC6H4MgBr in place of 4-MeOC6H4MgBr to obtain compound
4
(173 mg, 0.120 mmol, 48%) as black crystals. 1H NMR (500 MHz,
CDCl3): d=7.04 (s, 1H), 7.94–7.96 (d, J=8.3 Hz, 2H), 8.47–8.49 ppm (d,
J=8.3 Hz, 2H); 13C NMR (500 MHz, CDCl3/CS2): d=63.58, 65.43,
114.22, 128.77, 128.73, 135.42, 135.66, 140.18, 140.27, 141.51, 141.62,
141.65, 141.99, 142.03, 142.04, 142.53, 143.22, 143.57, 144.57, 144.62,
145.33, 145.34, 145.41, 145.47, 145.49, 145.81, 146.08, 146.13, 146.35,
146.43, 146.75, 147.27, 147.23, 147.77, 151.45, 154.16, 154.62 ppm; HRMS
(APCIÀ): m/z calcd for C67H5F3: 867.0343 [M]À; found: 867.0359.
C CHUTTGNERN(NNUG C6H5)AHCUTNGTREN(NGNU CH2Si(Me)2Ph) (8)
60A
The procedure described for compound 6a was performed by using com-
pound in place of compound to obtain compound (102 mg,
3
1
7
C60ACHTUNGTRENNUNG(C4H3S)H (5)
1
0.128 mmol, 18%) as black crystals. H NMR (500 MHz, CDCl3/CS2): d=
0.65 (s, 3H), 0.66 (s, 3H), 2.55 (d, J=14.6 Hz, 1H), 2.71 (d, J=14.6 Hz,
1H), 7.25–7.27 (m, 2H), 7.29–7.31 (m, 4H), 7.52–7.53 (m, 1H), 7.60–7.62
(m, 2H), 7.64–7.66 ppm (m, 1H); 13C NMR (500 MHz, CDCl3/CS2): d=
22.01, 22.04, 29.77, 30.47, 55.35, 68.66, 110.17, 114.85, 119.86, 123.55,
125.62, 128.31, 128.71, 128.72, 131.38, 133.26, 134.17, 135.03, 135.69,
136.18, 136.31, 140.23, 140.29, 140.54, 140.58, 141.17, 141.23, 141.58,
141.65, 141.97, 142.02, 142.04, 142.11, 142.31, 142.56, 142.57, 142.93,
143.28, 143.59, 144.26, 144.31, 144.35, 144.54, 144.56, 144.65, 144.72,
144.73, 145.38, 145.41, 145.49, 145.51, 145.81, 145.93, 146.15, 146.18,
146.20, 146.28, 146.35, 146.36, 146.40, 146.67, 146.86, 147.27, 147.59,
147.82, 148.58, 148.72, 149.43, 149.55, 154.52, 155.26, 158.00, 158.03 ppm;
HRMS (APCIÀ): m/z calcd for C75H18Si: 947.1178 [M]À; found:
947.1206.
A solution of (C4H3S)MgBr (5.37 mL, 0.85m, 4.58 mmol) in THF was
added to a solution of C60 (550 mg, 0.764 mmol) in 1,2-dichlorobenzene
(150 mL) that contained DMSO (0.33 mL, 4.58 mmol) at 258C. The color
of the solution gradually changed from purple to dark green. After stir-
ring for 48 h, a saturated aqueous solution of NH4Cl (1.0 mL) was added
to stop the reaction. The resulting dark-red solution was subjected to
vacuum distillation to remove the 1,2-dichlorobenzene. The residue,
which contained a small amount of 1,2-dichlorobenzene (about 0.5–
3 mL) was dissolved in toluene (200 mL) and passed through a pad of
silica gel to remove the magnesium salts. The mixture was concentrated
to obtain a solution (about 5–10 mL) that contained the product. Purifi-
cation of the product by column chromatography on silica gel (CS2/n-
hexane, 1:1 to 1:0) afforded the title compound (477 mg, 0.576 mmol,
1
56% yield) as black crystals. H NMR (500 MHz, CDCl3/CS2): d=6.95 (s,
À
C
(C6H4 CF3)
N
1H), 7.20–7.26 (m, 1H), 7.63–7.65 (dd, 1H), 7.92–7.93 ppm (dd, 1H);
13C NMR (500 MHz, CDCl3/CS2): d=63.68, 65.44, 103.77, 125.80, 126.11,
127.89, 133.33, 135.25, 136.31, 136.84, 140.23, 140.29, 140.32, 140.33,
140.54, 141.62, 141.65, 142.07, 142.60, 143.02, 143.24, 145.49, 145.51,
145.81, 144.69, 145.62, 146.19, 146.22, 146.35, 146.42, 146.72, 148.54,
151.95, 153.31 ppm; HRMS (APCIÀ): m/z calcd for C64H4S: 805.0034
[M]À; found: 805.0054.
The procedure described for compound 6a was performed by using com-
pound in place of compound 1 to obtain compound (11.0 mg,
4
9
1
0.190 mmol, 19%) as black crystals. H NMR (500 MHz, CDCl3/CS2): d=
0.51 (s, 3H), 0.57 (s, 3H), 2.53 (d, J=14.6 Hz, 1H), 2.73 (d, J=14.6 Hz,
1H), 7.26–7.29 (m, 2H), 7.31–7.34 (m, 4H), 7.52–7.53 (m, 1H), 7.57–7.59
(m, 2H), 7.64–7.66 ppm (m, 1H); 13C NMR (500 MHz, CDCl3/CS2): d=
22.87, 27.66, 29.77, 29.93, 55.37, 69.25, 110.17, 114.85, 119.86, 123.55,
125.62, 128.31, 128.71, 128.72, 131.38, 133. 26, 134.17, 135.03, 135.69,
136.18, 136.31, 140.23, 140.29, 140.54, 140.58, 141.17, 141.23, 141.58,
141.65, 141.97, 142.02, 142.04, 142.11, 142.31, 142.56, 142.57, 142.93,
143.28, 143.59, 144.35, 144.59, 144.63, 144.67, 144.91, 144.96, 144.98,
145.30, 145.34, 145.49, 146.70, 146.72, 146.81, 146.84, 147.02, 147.05,
147.13, 147.53, 147.76, 147.99, 148.45, 148.46, 148.72, 151.20, 154.23,
157.65, 158.25 ppm; HRMS (APCIÀ): m/z calcd for C76H17SiF3:
1015.1052 [M]À; found: 1015.1084.
À
C
(C6H4 OMe)
N
A solution of KOtBu (0.184 mL, 1.0m, 0.184 mmol) in THF (1.0m) was
added to a solution of compound 1 (76.0 mg, 0.0918 mmol) in PhCN at
258C. A dark-green solution of the potassium salt of compound 1 was im-
mediately obtained. After stirring for 30 min, PhSi(Me)2CH2Cl (0.33 mL,
1.86 mmol) and potassium iodide (0.305 g, 1.86 mmol) were added to the
solution. After stirring for 18 h at 1108C, a saturated aqueous solution of
NH4Cl (1.0 mL) was added to stop the reaction. Evaporation of volatile
compounds gave crude product 6a. Purification of the product by column
chromatography on silica gel (CS2/n-hexane, 1:4 to 1:1) and by prepara-
tive HPLC (Buckyprep column; eluent: toluene/2-propanol, 6:4) afforded
the title compound (18.8 mg, 0.0193 mmol, 21% yield) as black crystals.
Chem. Asian J. 2013, 8, 121 – 128
126
ꢀ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim